Entering text into the input field will update the search result below

Novartis and LabCorp among investors in developer of push button blood collection device

Nov. 18, 2016 8:28 AM ETNovartis AG (NVS) StockNVS, LHBy: Douglas W. House, SA News Editor
  • Seventh Sense Biosystems receives a $10M funding round from a group of investors that includes Novartis (NYSE:NVS) and LabCorp (NYSE:LH). The Medford-MA-based firm is developing a disposable blood collection device called Touch Activated Phlebotomy which used microscopic needles to collect a fingerstick-sized blood sample.
  • Controversial diagnostic start-up Theranos tried to develop a similar product before crashing amid investigations and failed operations.

Recommended For You

More Trending News

About NVS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
NVS--
Novartis AG